Table 1.

Data to be extracted from studies included within the review

	HIV	Hepatitis C	Active tuberculosis	LTBI
Bibliometric data	Author, year of publication, title of study
Study characteristics	Study design, study funding, country study carried out in, inclusion/exclusion criteria for participants, recruitment method, sample size, any remuneration for participants, location of screening/treatment (e.g. hostel, hospital, mobile screening unit), description of intervention, who is delivering intervention, study start-end date, assessment points, description of any comparison/control (including definition, selection source, any confounding factors identified and/or controlled for)
Participant characteristics	Sex/gender, age, ethnicity, history of imprisonment, comorbidities, reported to be taking injection drugs, non-injection drugs reported to be taking, primary condition(s), history of previously treated hepatitis C or TB
Treatment initiation	Number/percentage who initiated treatment from those referred, reasons for not initiating treatment (if known), type of treatment given
Treatment completion	Undetectable viral load	Number/percentage who completed treatment, method by which treatment adherence/completion measured, programme adherence techniques (e.g. DOTS, case manager, phone calls, housing of patients during treatment), number/percentage lost to follow-up and reasons why if stated (including number found to have died and, if specified, reasons for death)